| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Over the last 12 months, insiders at bioAffinity Technologies, Inc. have bought $0 and sold $0 worth of bioAffinity Technologies, Inc. stock.
On average, over the past 5 years, insiders at bioAffinity Technologies, Inc. have bought $99,997 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,448 shares for transaction amount of $0 was made by Edwards James Michael (Chief Financial Officer) on 2022‑09‑01.
| 2022-09-01 | Edwards James Michael | Chief Financial Officer | 2,448 – | $0 | $0 | -77.35% | ||
| 2022-08-31 | Rubin Gary D | director | 32,652 0.5281% | $3.06 | $99,997 | -77.35% | ||
| 2022-08-31 | GIRGENTI STEVEN | Executive Chairman | 40,916 – | $0 | $0 | -77.35% | ||
| 2022-08-31 | KNIGHT PETER S | director | 8,163 – | $0 | $0 | -77.35% | ||
| 2022-08-31 | Zannes Maria | President, CEO | 16,326 – | $0 | $0 | -77.35% |
| Rubin Gary D | director | 1584144 5.8135% | $462,728.46 | 1 | 0 | <0.0001% |
| GIRGENTI STEVEN | Executive Chairman | 861099 3.1601% | $251,527.02 | 1 | 0 | |
| Edwards James Michael | Chief Financial Officer | 30323 0.1113% | $8,857.35 | 1 | 0 | |
| KNIGHT PETER S | director | 22448 0.0824% | $6,557.06 | 1 | 0 | |
| Zannes Maria | President, CEO | 19897 0.073% | $5,811.91 | 1 | 0 |
$55,491,450 | 177 | 15.06% | $398.81M | |
$26,663,659 | 7 | -12.13% | $21.1B | |
$66,999 | 2 | -47.54% | $8.85M | |
bioAffinity Technologies, Inc. (BIAF) | $99,997 | 1 | -77.35% | $7.96M |
| Increased Positions | 9 | +50% | 94,098 | +17.57% |
| Decreased Positions | 7 | -38.89% | 117,498 | -21.94% |
| New Positions | 4 | New | 60,534 | New |
| Sold Out Positions | 3 | Sold Out | 30,132 | Sold Out |
| Total Postitions | 20 | +11.11% | 512,251 | -4.37% |
| Vanguard Group Inc | $117.00 | 1.45% | 260,869 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $45.00 | 0.55% | 99,551 | +12,370 | +14.19% | 2024-12-31 |
| Sheaff Brock Investment Advisors, Llc | $21.00 | 0.26% | 46,304 | +26,304 | +131.52% | 2024-12-31 |
| Captrust Financial Advisors | $13.00 | 0.16% | 27,885 | 0 | 0% | 2024-12-31 |
| State Street Corp | $8.00 | 0.1% | 17,600 | 0 | 0% | 2024-12-31 |
| Two Sigma Securities, Llc | $6.00 | 0.08% | 14,420 | +14,420 | New | 2024-12-31 |
| Northern Trust Corp | $6.00 | 0.08% | 13,662 | 0 | 0% | 2024-12-31 |
| Citadel Advisors Llc | $6.00 | 0.07% | 13,264 | +13,264 | New | 2024-12-31 |
| Creative Planning | $5.00 | 0.07% | 12,095 | 0 | 0% | 2024-12-31 |
| Xtx Topco Ltd | $5.00 | 0.06% | 10,616 | -648 | -5.75% | 2024-12-31 |